OCTRODE PERCUTANEOUS LEAD
Report
- Report Number
- 1627487-2011-01244
- Event Type
- Malfunction
- Date Received
- February 15, 2011
- Date of Event
- February 14, 2011
- Report Date
- February 14, 2011
- Manufacturer
- ST JUDE MEDICAL - NEUROMODULATION DIVISION
- Product Code
- GZB
- PMA / PMN Number
- P010032
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CT, US
- Reporter Occupation
- NOT APPLICABLE
Narratives
EVALUATION: METHOD: THE DEVICE HISTORY STERILIZATION RECORDS WERE REVIEWED. RESULTS: REVIEW OF THE DEVICE HISTORY RECORDS FOUND A NONCONFORMANCE RELATED TO THE PRODUCT; HOWEVER, THE NONCONFORMANCE WAS IDENTIFIED AS A COSMETIC ISSUE AND DID NOT AFFECT PRODUCT INTEGRITY OR PRODUCT FUNCTIONALITY. THE PRODUCT WAS, THEREFORE, APPROVED FOR USE. THE DHR ANOMALY IS NOT RELATED TO THE ALLEGED COMPLAINT. CONCLUSION: THE CAUSE OF THE REPORTED COMPLAINT COULD NOT BE DETERMINED FROM THE REVIEW OF THE DHR AND STERILIZATION RECORDS. SJM HAS LIMITED INFORMATION RELATED TO THE PT'S MEDICAL HISTORY AND IS UNABLE TO FORM AN OPINION AS TO THE RELEVANCY OF THE PT'S HISTORY TO THE EVENT REPORTED. SJM DEFERS TO THE PT'S PHYSICIAN REGARDING MEDICAL HISTORY.
DEVICE 1 OF 2. REFERENCE MFR REPORT: 1627487-2011-01245. THE PT REC'D HIS SCS SYSTEM, INCLUDING AN IPG AND PERCUTANEOUS LEAD, ON (B)(6) 2007. THE PT HAD ANOTHER PERCUTANEOUS LEAD IMPLANTED ON (B)(6) 2008. IT WAS REPORTED THAT THE PT LOST STIMULATION. DIAGNOSTIC TESTS EXHIBITED INVALID IMPEDANCES ON ONE OF THE LEADS, AND THE OTHER LEAD EXHIBITED LOW IMPEDANCES ON ALL LEAD CONTACTS. THE PT WAS ALLEGEDLY REPROGRAMMED USING THE LEAD WITH LOW IMPEDANCE READINGS. THE PT STATED HE HAD EFFECTIVE STIMULATION WITH ONLY ONE LEAD, AND NO FURTHER COMPLICATIONS HAVE BEEN REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | OCTRODE PERCUTANEOUS LEAD | SPINAL CORD STIMULATION LEAD | GZB | ST JUDE MEDICAL - NEUROMODULATION DIVISION | 3186 | 65196 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 42 YR |